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The biological significance of fimbrial phase variation in Salmonella serotypes is currently unknown. Expo-
sure to long polar (LP) fimbriae of Salmonella enterica serotype Typhimurium results in selection against lpf
phase ON cells of serotype Enteritidis during a subsequent challenge, suggesting that fimbrial phase variation
may be a mechanism to evade cross-immunity between Salmonella serotypes. This notion was tested by
assessing the effect of an immune response against serotype Typhimurium LP fimbriae on colonization of mice
with a serotype Enteritidis mutant in which the lpf promoter region was replaced with the Escherichia coli lac
promoter. During a challenge with a serotype Enteritidis mutant carrying the lac promoter in front of the lpf
operon, significantly lower numbers were recovered from organs and feces of mice previously immunized with
an lpf phase ON culture of serotype Typhimurium than from mice not previously exposed to LP fimbriae.
Immunization with the lpf phase ON culture of serotype Typhimurium elicited antibodies that cross-reacted
with a purified gluthathione-S-transferase–LpfA fusion protein of serotype Enteritidis. These data suggested
that cross-immunity against LP fimbrial proteins cannot be evaded if phase variation on the transcriptional
level is prevented by expressing the lpf operon from the lac promoter. These data hence support the idea that
phase variation of LP fimbriae is a mechanism to evade cross-immunity between serotypes Enteritidis and
Typhimurium.
Expression of several fimbrial antigens of Salmonella en-
terica serotype Typhimurium, including type 1 fimbriae, long
polar (LP) fimbriae, and plasmid-encoded (PE) fimbriae, is
regulated by phase variation (19, 21–23, 28). Conventional
wisdom holds that phase variation of surface antigens is a
mechanism for immune evasion. However, the significance of
fimbrial phase variation in serotype Typhimurium is uncertain
because this pathogen is not able to evade immunity against
constitutively expressed surface structures, such as the O anti-
gen repeat of its lipopolysaccharide (LPS), and is hence not
able to cause recurrent infections.
While serotype Typhimurium is unable to evade an adaptive
immune response encountered in a host with recent exposure
to this organism, it does evade cross-immunity against Salmo-
nella serotypes expressing different O antigen repeat units (15).
For instance, immunization of mice or chickens with S. enterica
serotype Enteritidis does not confer protection against chal-
lenge with serotype Typhimurium and vice versa, vaccination
with serotype Typhimurium does not protect against challenge
with serotype Enteritidis (7, 12, 20). The O antigen repeat units
of serotypes Enteritidis and Typhimurium share the trisaccha-
ride backbone (mannose-rhamnose-galactose) which is termed
the O12 antigen. However, the two serotypes differ in the sugar
residues branching from the mannose residues in the trisac-
charide backbone of their O antigen repeat units. In serotype
Enteritidis, the branching sugar is tyvelose (O9 antigen), while
in serotype Typhimurium the O antigen has abequose attached
as the side unit to mannose (O4 antigen). Analysis of the
serologic response against serotypes Typhimurium and Enter-
itidis suggests that the O4 antigen and the O9 antigen are
immunodominant determinants of their lipopolysaccharides
(LPS), respectively. For instance, exposure to serotype Enter-
itidis elicits higher antibody titers against the O9 antigen than
against the O12 antigen (2). Similarly, immunization with se-
rotype Typhimurium results in higher titers against the O4
antigen than the O12 antigen (26).
Antibody titers may not be a reliable indicator for immunity
against Salmonella serotypes since cellular immunity is known
to contribute to protection. Nonetheless, there is convincing
experimental evidence that expression of the O9 or O4 anti-
gens has important consequences for cross-immunity. Immu-
nization of mice with a serotype Enteritidis aroA mutant elicits
protection against challenge with a virulent Enteritidis strain
(expressing the O9 antigen) but not against a virulent strain of
serotype Typhimurium (expressing the O4 antigen). However,
cross-protection between both serotypes is observed when
mice immunized with the Enteritidis aroA strain are chal-
lenged with a virulent serotype Typhimurium mutant that is
genetically engineered to express the O9 antigen instead of the
O4 antigen (12). These data suggest that O antigen polymor-
phism is a mechanism for the evasion of cross-immunity be-
tween serotypes Enteritidis and Typhimurium.
While serotypes Enteritidis and Typhimurium evade cross-
immunity against LPS by O antigen polymorphism, other sur-
face structures are well conserved between these organisms.
For instance, the primary structure of LpfA fimbrial proteins
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of serotypes Typhimurium and Enteritidis differs by only one
amino acid. Rabbit serum raised against a purified glutha-
thione-S-transferase (GST)-LpfA fusion protein is strongly
cross-reactive with a purified GST-LpfA fusion protein from
serotype Enteritidis (20). Furthermore, immunization of mice
with an lpf phase ON culture of serotype Typhimurium results
in selection against lpf phase ON variants of serotype Enteri-
tidis during a subsequent challenge. In contrast, no selection
against lpf phase ON variants of serotype Enteritidis is ob-
served during a challenge of mice previously immunized with a
serotype Typhimurium lpf deletion mutant (20). These data
support the idea that cross-immunity elicited by the cross-
reactive LpfA fimbrial antigen of serotypes Typhimurium and
Enteritidis is evaded by phase variation. However, vaccination
with an lpf phase ON culture of serotype Typhimurium does
not confer protection against mortality, nor does it reduce
organ colonization or fecal counts observed during a challenge
with serotype Enteritidis, presumably because lpf phase OFF
variants are able to evade cross-immunity (20).
Although the available data are consistent with the idea that
lpf phase variation is a mechanism to evade cross-immunity
between Salmonella serotypes, this evidence is indirect. Vali-
dation of this hypothesis requires direct evidence that a re-
sponse against LP fimbrial proteins of serotype Typhimurium
will result in cross-immunity against a serotype Enteritidis
strain which constitutively expresses the lpf operon. To this
end, we constructed and characterized a serotype Enteritidis
strain in which the lpf promoter region was replaced with the
promoter of the Escherichia coli lactose operon.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The E. coli strains TA One Shot and
Top 10F9 were purchased from Invitrogen. E. coli strains S17-1 lpir (25) and
DH5a (9) have been described previously. Derivatives of serotypes Typhimurium
strain ATCC 14028 and serotype Enteritidis strain CDC SSU79998 used in this
study are listed in Table 1. All bacteria were routinely cultured in Luria-Bertani
(LB) broth or on plates (16). If appropriate, antibiotics were included at the
following concentrations: nalidixic acid, 50 mg/ml (LB1Nal); chloramphenicol,
30 mg/ml (LB1Cm); kanamycin, 100 mg/ml (LB1Km); carbenicillin, 100 mg/ml
(LB1Cb); and tetracycline, 20 mg/ml (LB1Tc). When required, the Lac indica-
tor 5-bromo-4-chloro-3-indoyl-b-galactopyranoside (X-Gal) was added to LB
plates at a final concentration of 40 mg/liter (LB1X-Gal). If appropriate, the
alkaline phosphatase indicator 5-bromo-4-chloro-3-indolylphosphate (X-P) was
added to LB plates at a final concentration of 40 mg/liter (LB1X-P).
Construction of mutants. A mutant carrying a transcriptional fusion between
the lpf promoter region and the promoterless lacZYA genes was constructed by
PCR, amplifying the 1,384-bp fragment located immediately upstream of lpfA
using the primers 59-CCCGGGAATGGAGTGTATAGAGGTGGG-39 (engi-
neered SmaI site at the 59 end) and 59-TCTAGACTGTTGACCTTCAAGACA
GATC-39 (engineered XbaI site at the 59 end). The PCR product was cloned into
plasmid pCRII (Invitrogen), and the insert was excised by SmaI-XbaI digestion
and cloned into SmaI-XbaI-digested suicide vector pFUSE (5) to give suicide
plasmid pFUSE36 (Fig. 1). E. coli strain S17-1 lpir(pFUSE36) was conjugated
with serotype Typhimurium strain IR715 (nalidixic acid-resistant wild type), and
exconjugants were selected on LB1Nal1Cm plates. One exconjugant was se-
lected and termed AJB589 (Fig. 1).
For constructing a serotype Enteritidis mutant carrying the lac promoter in
place of the lpf promoter, the lac promoter was PCR amplified from pBluescript
SK1 (24) using the primer 59-CAGTCGACGTTATCCCCTGATTC-39 (engi-
neered SalI site at the 59 end) and the T7 primer and cloned into plasmid pCRII
(Invitrogen). The insert was excised by SalI-SacI digestion and cloned into
SalI-SacI-digested suicide vector pGP704 (14) to give rise to suicide plasmid
pTN29. A 1,095-bp DNA fragment extending from 21 bp upstream to 1,074 bp
downstream of the lpfA start codon was PCR amplified using the primers 59-G
GAGCTCTTCTGTTATCTACCGTC-39 (engineered SacI site at the 59 end)
and 59-CAGAATTCTCCAGCCGTCCATG-39 (engineered EcoRI site at the 59
end). The PCR product was cloned into plasmid pCRII (Invitrogen), and the
insert was excised by SacI-EcoRI digestion and cloned into SacI-EcoRI-digested
pTN29 to give rise to suicide plasmid pTN30. A 1,095-bp DNA fragment ex-
tending from bp 1527 to 476 upstream of the lpfA start codon was PCR amplified
using the primers 59-TCGAGATCTTCCTCCTGCATAG-39 (engineered BglII
site at the 59 end) and 59-CCACAAGTCGACTTATCACTGCG-39 (engineered
SalI site at the 59 end). The PCR product was cloned into plasmid pCRII
(Invitrogen), and the insert was excised by BglII-SalI digestion and cloned into
BglII-SalI-restricted pTN30 to give rise to pTN46. The chloramphenicol resis-
tance gene was PCR amplified from plasmid pACYC184 using the primers
59-GTCGACCTTAAAAAAATTACGCCCCGC-39 (engineered SalI site at the
59 end) and 59-GTCGACGCCGAATAAATACCTGTGACG-39 (engineered
SalI site at the 59 end) and cloned into plasmid pCRII (Invitrogen), and the
SalI-restricted insert was cloned into SalI-restricted pTN46 to give rise to pTN62
(Fig. 2). E. coli strain S17-1 lpir (pTN62) was conjugated with serotype Enter-
itidis strain TN2 (nalidixic acid-resistant wild type), and exconjugants were se-
lected on LB1Nal1Cm plates. Exconjugants were patched onto LB1Cb plates,
and a mutant which was resistant to chloramphenicol but sensitive to carbeni-
cillin was identified and termed TN7 (Fig. 2).
A serotype Enteritidis mutant carrying a deletion of the lpf operon was gen-
erated as previously described for constructing a serotype Typhimurium lpf
deletion mutant using suicide plasmid pMS1208 (20). Plasmid pMS1208 confers
carbenicillin resistance. Furthermore, pMS1208 contains a kanamycin resistance
cassette (KIXX, Pharmacia) that is flanked on one side by a 1.5-kb DNA region
upstream of lpfA and on the other side by a 1.2-kb DNA region downstream of
lpfE (20). Upon conjugative transfer, homologous recombination of the lpfA
upstream and the lpfE downstream DNA regions in pMS1208 with the homol-
ogous DNA regions in the serotype Enteritidis (TN2) chromosome will result in
deletion of the lpf operon and insertion of the kanamycin resistance gene. E. coli
strain S17-1 lpir(pMS1208) was conjugated with serotype Enteritidis strain TN2,
and exconjugants were selected on LB1Nal1Km plates. Exconjugants were
patched onto LB1Cb plates, and a mutant which was resistant to kanamycin but
sensitive to carbenicillin was identified and termed TN11.
An alkaline phosphatase-negative strain of serotype Enteritidis was con-
structed by insertional inactivation of the phoN gene. The phoN gene of serotype
Enteritidis was PCR amplified using the primer pair 59-GACTCTAGAATAAC
CGTCCGGGAAATG-39 (engineered XbaI site at the 59 end) and 59-TAACC
CGGGATTTGGTGGAGAGTG-39 (engineered SmaI site at the 59 end). The
PCR product was digested with SmaI and XbaI and cloned into EcoRV-XbaI-
restricted suicide vector pGP704 (14), giving rise to plasmid pTN102. A kana-
mycin resistance cassette (KSAC; Pharmacia) digested with SacI was cloned into
plasmid pTN102 after linearizing it at the SacI restriction site that is present in
the phoN open reading frame. The resulting plasmid, pTN104, was introduced
into serotype Enteritidis strains TN2 (wild type) and TN7 (Plac::lpfABCDE) by
conjugation with E. coli strain S17-1 lpir, and exconjugants were selected on
LB1Nal1Km plates. Exconjugants were patched onto LB1Cb plates, and mu-
tants which were resistant to kanamycin (KSAC) but sensitive to carbenicillin
(pGP704) were identified and termed TN17 (phoN) and TN18 (phoN Plac::
lpfABCDE).
To verify that expression of the lpf operon in strain TN18 (phoN Plac::lpfAB
CDE) was not regulated by phase variation, a transcriptional fusion between lpfE
and the phoA gene of E. coli was constructed. The lpfE gene was PCR amplified
using the primer pair 59-GCTCTAGACCGATGGCGTAAA-39 (engineered
XbaI site at the 59 end) and 59-AGGATCCGCCCTCAGTGATTATTCGTAT
G-39 (engineered BamHI site at the 59 end), digested with XbaI and BamHI, and
TABLE 1. S. enterica strains used in this study
Strain Description Reference
IR715 Serotype Typhimurium ATCC 14028 Nalr 27
TN3 IR715 aroA::Tn10 (Tcr) lpfABCDE::lacZYA (Cmr) 20
TN4 IR715 aroA::Tn10 (Tcr) DlpfABCDE (Kmr) 20
AJB589 IR715 Plpf::lacZYA (Cm
r) This study
TN2 Serotype Enteritidis CDC SSU7998 Nalr 20
TN5 TN2 lpfABCDE::lacZYA (Cmr) 20
TN7 TN2 Plac::lpfABCDE (Cm
r) This study
TN11 TN2 DlpfABCDE (Kmr) This study
TN17 TN2 phoN::Kmr This study
TN18 TN2 Plac::lpfABCDE (Cm
r) phoN::Kmr This study
TN19 TN2 phoN::Kmr lpfABCDE::phoA (Cbr) This study
TN20 TN2 Plac::lpfABCDE::phoA (Cm
r Cbr) phoN::Kmr This study
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cloned into XbaI-BamHI-digested plasmid pUJ10 (8) to give rise to plasmid
pTN106. An XhoI-XbaI fragment of pTN106 containing a promoterless phoA
gene fused immediately downstream to the stop codon of lpfE was cloned into
SalI-XbaI-digested suicide vector pGP704 to give rise to plasmid pTN107. Plas-
mid pTN104 was introduced into serotype Enteritidis strains TN17 (phoN) and
TN18 (phoN Plac::lpfABCDE) by conjugation with E. coli strain S17-1 lpir. Excon-
jugants were selected on LB1Nal1Cb plates and termed TN19 (phoN
lpfABCDE::phoA) and TN20 (phoN Plac::lpfABCDE::phoA).
Mutations in AJB589, TN7, and TN11 were confirmed by Southern hybrid-
ization. Isolation of genomic DNA and Southern transfer of DNA onto a nylon
membrane were performed as recently described (1). Labeling of nucleotide
probes and detection of hybrids were performed using the labeling and detection
kit (nonradioactive) from NEN. Deletion of the lpf operon was confirmed using
EcoRI-digested genomic DNA of TN11 and its parent (TN2) and a DNA probe
specific for lpfCD (the insert of plasmid pMS1039) (4) and an lpfA-specific DNA
probe. Replacement of the lpf promoter region with a DNA region containing a
chloramphenicol resistance gene and the lac promoter was confirmed using
EcoRI-digested genomic DNA of TN7 and its parent (TN2) and a DNA probe
generated by labeling the chloramphenicol resistance gene excised by SalI re-
striction of pTN62. Insertion of pFUSE36 into the chromosome was confirmed
FIG. 1. Construction of a single-copy transcriptional fusion between the lpfA upstream region and lacZYA. A restriction map of the serotype
Typhimurium (IR715) lpf promoter region is shown at the top (open arrows indicate genes). Suicide vector pFUSE36 carrying the lpf promoter
region cloned in front of the promoterless lacZYA genes (solid arrows) of E. coli is shown in the middle. Integration of pFUSE36 into the serotype
Typhimurium (IR715) chromosome by homologous recombination is indicated (cross). The resulting strain (AJB589) carries a transcriptional
fusion between the lpfA upstream region and lacZYA, which is shown at the bottom. The sizes of genomic PstI restriction fragments of strains IR715
and AJB589 hybridizing with an lpfA-specific DNA probe are indicated.
FIG. 2. Replacement of the yhjY-lpfA intergenic region with the E. coli lac promoter using allelic exchange. Hatched lines indicate homologous
recombination events between the genome of serotype Enteritidis strain TN2 (top) and suicide plasmid pTN62 (middle) which give rise to the
genetic organization in serotype Enteritidis strain TN7 (bottom). Arrows indicate the positions and orientations of genes. A black bar indicates
the position of the lac promoter region (Plac). Cm, chloramphenicol resistance gene; Ap, ampicillin resistance gene.
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by performing Southern hybridization with PstI-digested genomic DNA of strain
AJB589 and its parent (IR715). The lpfA-specific DNA probe used in this
Southern hybridization has been described previously (3).
The yhjY-lpfA intergenic region was PCR amplified from strain TN7 using the
primers 59-TCGAGATCTTCCTCCTGCATAG-39 and 59-CAGAATTCTCCA
GCCGTCCATG-39. To determine the orientation of the chloramphenicol resis-
tance gene and to confirm the presence of the lac promoter, the nucleotide
sequence of the PCR product was analyzed. Nucleotide sequence analysis was
performed by the Gene Technology Laboratory at Texas A&M University. Nu-
cleotide sequences were analyzed using the MacVector 6.0.1 software package
(Oxford Molecular Group).
Animal experiments. Female (8- to 10-week-old) CBA/J mice were used
throughout this study. Fresh fecal pellets were taken from mice prior to infection,
suspended in phosphate-buffered saline (PBS), and spread on LB plates con-
taining the appropriate antibiotics to ensure that the indigenous microflora was
antibiotic sensitive. Prior to immunization or infection of mice, all bacteria were
cultured as static overnight cultures in LB broth. In all experiments the bacterial
titer of the inoculum was determined by spreading serial 10-fold dilutions on LB
plates containing the appropriate antibiotics. After inoculation of mice, fresh
fecal pellets were collected at least three times per week and suspended in PBS,
and serial 10-fold dilutions were spread onto LB agar plates containing the
appropriate antibiotics. For TN3 (lpfABCDE::lacZYA aroA::Tn10), agar plates
were supplemented with X-Gal to quantify bacteria containing the lpf operon in
the phase ON or phase OFF expression state.
For competitive infection experiments, groups of six mice were inoculated
intragastrically at a total dose of 109 CFU/animal. The inoculum consisted of a
1:1 mixture of two bacterial strains that were distinguishable by their antibiotic
resistance profiles. Mice were euthanized at 5 days postinfection, Peyer’s patches,
mesenteric lymph nodes, and spleens were collected and homogenized in 5 ml of
PBS using a Stomacher (Tekmar, Cincinatti, Ohio), and serial 10-fold dilutions
were spread onto LB agar plates containing the appropriate antibiotics. Data
were normalized by dividing the output ratio (CFU of the mutant/CFU of the
wild type) by the input ratio (CFU of the mutant/CFU of the wild type). All data
were converted logarithmically prior to the calculation of averages and statistical
analysis. A Student’s t test was used to determine whether the mutant/wild-type
ratio recovered from infected organs or fecal pellets was significantly different
from the mutant/wild-type ratio present in the inoculum.
Three groups of eight mice were used for an immunization experiment. One
group served as the naive control, while the remaining two groups were immu-
nized with serotype Typhimurium strains TN3 (lpfABCDE::lacZYA aroA::Tn10)
or TN4 (DlpfABCDE aroA::Tn10). Immunization was performed intragastrically
at a dose of approximately 109 CFU/animal contained in a 0.2-ml volume.
Immunized mice were then boosted with the same vaccine strain at 14 days
postimmunization. At 14 days postbooster immunization, mice were anesthetized
using Rodent cocktail (42.8 mg of ketamine plus 8.6 mg of xylazine plus 1.4 mg
of acepromazine; administer 0.5 to 0.7 ml/kg of body weight intraperitoneally),
0.05 ml of blood was collected by periorbital bleed, and samples from each
immunization group were pooled. Prior to challenge, fresh fecal pellets were
collected from immunized mice to identify animals that had developed long-term
carriage, and these animals were removed from the experiment. All three groups
were challenged with serotype Enteritidis strain TN7 at day 80 postimmuniza-
tion. The infection was monitored for 28 days postchallenge by collecting fresh
fecal pellets. Statistical analysis of the data was performed using the Wilcoxon
rank sum test. The immunization experiment was repeated with three groups of
five mice. Immunization and challenge were performed as described above, but
mice were euthanized at 8 days postchallenge and Peyer’s patches, mesenteric
lymph nodes, and spleens were collected. Organs were homogenized in 5 ml of
PBS using a Stomacher (Tekmar), and serial 10-fold dilutions were spread onto
LB agar plates containing the appropriate antibiotics. A Student’s t test was used
to determine whether the numbers of bacteria recovered from infected organs
were significantly different between experimental groups.
ELISA. Plasmid pTN66 contains a fragment of the serotype Enteritidis lpfA
gene encoding the C-terminal 162 amino acids of LpfA (corresponding to the
mature protein after cleavage of the signal peptide) cloned into plasmid pGEX-
4T-2 to generate a translational fusion between GST and LpfA (20). Serotype
Enteritidis GST-LpfA fusion protein was prepared from E. coli strain Top10F9
(pTN66) as described previously (20). The concentration of purified GST-LpfA
protein was determined using a Bradford assay kit (Bio-Rad). Enzyme-linked
immunosorbent assay (ELISA) analysis was performed by using a protocol de-
scribed previously (29). In brief, 96-well polySorp ELISA plates (Nunc) were
coated with antigen by adding GST-LpfA of serotype Enteritidis (20 mg/well) to
each well. To remove antibodies that were not directed against LpfA, the serum
collected from mice was absorbed with strain Top10F9(pGEX-T4-2) grown in LB
supplemented with 2 mM IPTG (isopropyl-b-D-thiogalactopyranoside) using a
protocol described previously (10). Antigen-coated plates were blocked with 0.2
ml of 3% Blotto (3% powdered skim milk, 0.04% antifoam A, 0.05% Tween 20,
0.1% sodium azide in PBS) for 4 h at 37°C. Blocked plates were then washed
once with H2O, and mouse serum (0.05 ml/well) was added to antigen-coated
plates in duplicate two fold serial dilutions with 3% Blotto as the diluent. The
plates were incubated overnight and washed 10 times with H2O. Binding of
mouse serum was detected by using goat anti-mouse immunoglobulin G (IgG)-
alkaline phosphatase (AP) conjugate (Sigma) diluted 1:1,000 in 3% Blotto.
Plates were incubated with secondary antibodies overnight at 37°C and then
washed 10 times with H2O. Detection was performed with 0.05 ml of p-nitro-
phenylphosphate (1 mg/ml; Sigma) diluted in glycine buffer (0.1 M glycine, 1 mM
MgCl2, 1 mM ZnCl2, pH 10.4). Reactions were stopped by addition of 0.05 ml
of 0.1 M EDTA.
To remove antibodies that were not directed against LpfA, serum collected
from a rabbit immunized with GST-LpfA fusion protein (20) was absorbed with
a serotype Enteritidis strain in which the entire lpf operon was removed by
deletion (TN11) using a protocol described previously (10). ELISA with whole
serotype Enteritidis cells was performed by adjusting bacterial cultures to a final
protein concentration of 2 mg/ml (Bradford assay) and adding 50 ml of the
bacterial suspension to each well. After addition of 20 ml of a 1% sodium azide
solution (in PBS) to each well, 96-well polySorp ELISA plates (Nunc) were
allowed to dry overnight at 37°C. Antigen-coated plates were blocked with 0.2 ml
of 3% Blotto for 4 h at 37°C. Blocked plates were then washed once with H2O,
and rabbit serum (0.05 ml/well) was added to antigen-coated plates in duplicate
twofold serial dilutions with 3% Blotto as the diluent. The plates were incubated
overnight and washed ten times with H2O. Binding of rabbit serum was detected
using goat anti-rabbit IgG-AP conjugate (Sigma) diluted 1:1,000 in 3% Blotto.
Plates were incubated with secondary antibodies overnight at 37°C and then
washed 10 times with H2O. Detection was performed as described above.
The ELISA procedure described by Smith and coworkers (26) was modified
and used for the detection of serum antibodies directed against LPS from sero-
type Typhimurium and serotype Enteritidis. Purified LPS of serotype Typhimu-
rium and serotype Enteritidis prepared by phenol extraction (purchased from
Sigma) was resuspended in coating buffer (0.1 M sodium carbonate, 1.0 M NaCl,
pH 9.6), and 96-well polySorp ELISA plates (Nunc) were coated with antigen by
adding 5 mg to each well. Plates were then covered and incubated overnight at
37°C. The plates were emptied and blocked for 30 min in blocking buffer (PBS
plus 0.05% Tween 20 plus 1% bovine serum albumin), and mouse serum (0.05
ml/well) was added to antigen-coated plates in duplicate twofold serial dilutions
with blocking buffer as the diluent and incubated for 1 at 37°C. Plates were then
washed three times in washing buffer (PBS plus 0.05% Tween 20), and binding
of mouse serum was detected by using goat anti-mouse IgG-AP conjugate or goat
anti-mouse IgA-AP conjugate (Sigma) diluted 1:1,000 in blocking buffer. Plates
were incubated with secondary antibodies for 1 h at 37°C and then washed three
times with washing buffer. Detection was performed as described above.
In all ELISA experiments, titers were expressed as the inverse of the highest
dilution that gave an A405 value in an ELISA plate reader (MK700 microplate
reader; Dynatech) that was above background levels detected in wells that were
not incubated with primary serum.
RESULTS
Construction of a serotype Enteritidis strain expressing the
lpf operon from the lac promoter. The goal of this study was
to construct and characterize a serotype Enteritidis strain in
which expression of LP fimbriae is not regulated by phase
variation. Since the mechanism of LP fimbrial phase variation
is currently unknown, it was not straightforward to construct a
strain in which the lpf operon was locked ON. To overcome
this problem, the promoter region of the lpf operon was re-
placed with the promoter of the lactose (lac) operon of E. coli
to eliminate phase variation of LP fimbriae.
Using a strain carrying an lpfABCDE::lacZYA reporter gene
fusion, we have previously demonstrated that expression of the
lpf operon is regulated by phase variation (21). To determine
whether fimbrial phase variation is mediated by a promoter
located upstream of lpfA, we constructed a strain (AJB589) in
which the promoterless lacZYA reporter genes were integrated
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into the bacterial chromosome and directly fused to the yhjY-
lpfA intergenic region (proximal to lpfA) (Fig. 1). Strain
AJB589 yielded both Lac1 and Lac2 colony phenotypes on
LB1X-Gal agar plates. Alternation between Lac1 (phase ON)
and Lac2 (phase OFF) phenotypes occurred by a heritable
phase variation mechanism, since inoculation of broth cultures
with bacteria picked from a Lac1 colony gave rise to a consid-
erably higher proportion of Lac1 colonies than inoculation
with bacteria picked from a Lac2 colony. These data suggested
that expression of the lpf operon was driven by a phase-variable
promoter located upstream of the lpfA start codon.
The yhjY-lpfA intergenic region (bp 21 to 476 upstream of
lpfA) of serotype Enteritidis strain TN2 was replaced by allelic
exchange with a DNA region containing a chloramphenicol
resistance cassette and the lac promoter using suicide plasmid
pTN62 (Fig. 2). Allelic exchange in the resulting strain (TN7)
was confirmed by Southern blot analysis using a DNA probe
specific for the chloramphenicol resistance gene (data not
shown). Furthermore, the yhjY-lpfA intergenic region of strain
TN7 was PCR amplified and cloned, and its sequence was
determined to verify the presence of the lac promoter up-
stream of lpfA. No mutations were detected in the sequence of
the chloramphenicol resistance gene or the lac promoter.
Characterization of a serotype Enteritidis strain expressing
the lpf operon from the lac promoter. The phoN gene in sero-
type Enteritidis strains TN2 (wild type) and TN7 (Plac::
lpfABCDE) was inactivated by inserting a kanamycin resistance
cassette, and the resulting strains were termed TN17 (phoN)
and TN18 (phoN Plac::lpfABCDE), repectively. To study ex-
pression of the lpf operon on the transcriptional level, a pro-
moterless phoA reporter gene was inserted immediately down-
stream of the stop codon of lpfE in strains TN17 (phoN) and
TN18 (phoN Plac::lpfABCDE) to give rise to strains TN19
(phoN lpfABCDE::phoA) and TN20 (phoN Plac::lpfABCDE::
phoA), respectively. Strain TN19 (phoN lpfABCDE::phoA)
yielded both PhoA1 and PhoA2 colony phenotypes on
LB1X2P agar plates. In contrast, strain TN20 (phoN Plac::
lpfABCDE::phoA) only gave rise to PhoA1 colonies on
LB1X2P agar plates, confirming that phase variation at the
transcriptional level had been eliminated by replacing the lpf
promoter region with the lac promoter.
Serotype Enteritidis strain TN7 (Plac::lpfABCDE) was ana-
lyzed by ELISA to verify that LpfA fimbrial protein was ex-
pressed in this strain. The reactivity of TN7 with rabbit anti-
LpfA serum was compared to that of an isogenic serotype
Enteritidis strain carrying a deletion of the lpf operon. The
entire lpf operon was deleted from serotype Enteritidis strain
TN2 by allelic exchange as previously described for serotype
Typhimurium (20). The resulting serotype Enteritidis strain
was termed TN11, and the absence of sequences hybridizing
with lpfA was confirmed by Southern hybridization (data not
shown). Rabbit serum raised against purified GST-LpfA fusion
protein of serotype Typhimurium has been described previ-
ously (20) and was absorbed with serotype Enteritidis strain
TN11 to remove antibodies that were not directed against LP
fimbrial proteins. Expression of LpfA in serotype Enteritidis
strains TN7 (Plac::lpfABCDE) and TN11 (DlpfABCDE) was
assessed by ELISA using absorbed rabbit anti-GST-LpfA se-
rum. Rabbit anti-GST-LpfA serum contained 16-fold-higher
IgG titers against strain TN7 (Plac::lpfABCDE) than against
strain TN11 (DlpfABCDE), confirming expression of LpfA in
strain TN7 (Table 2).
Since the lac promoter may be expressed in different host
environments and at different levels than the native lpf pro-
moter, we next addressed the question of whether the presence
of the lac promoter in front of the lpf operon resulted in at-
tenuation of serotype Enteritidis for mouse virulence. For this
purpose, we compared the ability of TN7 (Plac::lpfABCDE) to
colonize murine tissues during a competitive infection with the
isogenic wild type (TN2). A group of five mice were infected
intragastrically with a 1:1 mixture of TN7 and TN2. Bacteria
were recovered from fecal pellets for 5 days postinfection, and
on the fifth day bacteria were recovered from organs. The
TN7/TN2 ratios recovered from feces or infected organs were
not significantly different from the ratio present in the inocu-
lum (Fig. 3). These data suggested that expression of the lpf
operon from the lac promoter did not result in marked atten-
uation of serotype Enteritidis for mouse virulence.
Cross-immunity between serotype Typhimurium and sero-
type Enteritidis strain TN7. The immune response generated
during vaccination with a live attenuated lpf phase ON Typhi-
murium strain is sufficient to cause selection against lpf phase
ON variants of serotype Enteritidis during a subsequent chal-
lenge (20). However, similar total numbers of serotype Enter-
itidis are recovered from naive mice and mice previously ex-
posed to a live attenuated lpf phase ON variant of serotype
Typhimurium. These data can be explained by assuming that
serotype Enteritidis lpf phase OFF variants can evade immu-
nity against LP fimbrial proteins, giving rise to similar bacterial
loads in organs and feces of naive animals and animals previ-
ously exposed to LP fimbriae. Thus, phase variation of the lpf
operon may be a mechanism to evade cross-immunity between
Salmonella serotypes. This hypothesis implies that in case fim-
brial phase variation is prevented, the total numbers of sero-
type Enteritidis recovered from animals with immunity to se-
TABLE 2. Anti-LpfA antibodies present in rabbit or murine serum
Serum Antigen IgGtiter
Rabbit anti-GST-LpfA Enteritidis TN7 (Plac::lpfABCDE) 2,560
Rabbit anti-GST-LpfA Enteritidis TN11 (DlpfABCDE) 160
Mouse anti-Typhimurium TN3
(lpfABCDE::lacZYA)
Purified Enteritidis GST-LpfA 480
Mouse anti-Typhimurium TN4
(DlpfABCDE)
Purified Enteritidis GST-LpfA 10
FIG. 3. Ratio of mutant to wild type recovered from mice infected
with an equal mixture of serotype Enteritidis strain TN7 (Plac::lpfABCDE)
and the isogenic wild type (TN2). Data are given as means 6 standard
deviation. PP, Peyer’s patches.
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rotype Typhimurium LP fimbrial proteins during a challenge
would be significantly reduced compared to the numbers re-
covered from naive control mice. A vaccination and challenge
study was performed to test this hypothesis. Since naive sus-
ceptible mice challenged with virulent serotype Enteritidis die
before adaptive immunity is fully induced (usually between
days 6 and 10 postinfection), colonization levels cannot be
compared with those observed in immune animals at later time
points. To avoid this pitfall, we performed immunization stud-
ies with a resistant mouse lineage, CBA/J. CBA/J mice do not
succumb to oral challenge with virulent serotype Enteritidis.
Thus, the bacterial load in naive and vaccinated groups can be
compared until bacteria are cleared from the animals, which
may take more than 4 weeks.
We reasoned that cross-immunity between serotypes Typhi-
murium and Enteritidis elicited by exposure to LP fimbrial
proteins could be assessed by comparing the responses elicited
by vaccination with an lpf phase ON culture of serotype Ty-
phimurium strain TN3 (aroA lpfABCDE::lacZYA) with that
induced by immunization with an isogenic strain (TN4) ex-
pressing all antigens except LP fimbriae (aroA Dlpf). Groups of
eight mice were immunized intragastrically with either an lpf
phase ON culture of serotype Typhimurium strain TN3 (aroA
lpfABCDE::lacZYA) or a culture of serotype Typhimurium
strain TN4 (aroA Dlpf). Both vaccination groups were boosted
14 days postimmunization with the same strain. Prior to chal-
lenge, two and three animals were removed from the groups of
mice immunized with strains TN4 and TN3 respectively, be-
cause the animals had developed long-term carriage of the
vaccine strain. To allow nonspecific immune mechanisms,
such as macrophage activation, to return to their normal lev-
els, challenge with serotype Enteritidis strain TN7 (Plac::
lpfABCDE) was performed at 80 days post-booster immuniza-
tion. In addition, a group of eight naive mice of the same age
were challenged with the same dose of TN7.
Fecal shedding of serotype Enteritidis strain TN7 (Plac::
lpfABCDE) was monitored by determining bacterial numbers
recovered from fecal pellets of mice collected on days 1, 2, 3,
4, 5, 6, 7, 8, 9, 10, 11, 13, 15, 17, 19, 21, 23, and 28 postchal-
lenge. Numbers recovered from fecal pellets varied over a wide
range, which may reflect differences between animals as well as
the fact that Salmonella serotypes tend to be shed intermit-
tently with the feces. The average numbers of serotype Enter-
itidis TN7 recovered from feces of mice immunized with sero-
type Typhimurium strain TN3 (aroA lpfABCDE::lacZYA) were
consistently lower than those recovered from the naive control
group (Fig. 4). The difference was largest on day 19 postchal-
lenge, when the average number of serotype Enteritidis TN7
recovered from naive mice was approximately 5,500-fold
higher than that recovered from mice immunized with strain
TN3 (aroA lpfABCDE::lacZYA). Statistical analysis revealed
that for days 2, 4, 6, 7, 8, 9, 11, 13, 15, 17, 19, 21, 23, and 28
postchallenge, the numbers of serotype Enteritidis TN7 recov-
ered from mice immunized with serotype Typhimurium strain
TN3 (aroA lpfABCDE::lacZYA) were significantly lower than
those recovered from the naive group (P , 0.05).
Mice immunized with serotype Typhimurium strain TN4 (aroA
Dlpf) shed serotype Enteritidis strain TN7 (Plac::lpfABCDE) on
average at lower numbers than naive mice but at higher num-
bers than mice immunized with serotype Typhimurium strain
TN3 (aroA lpfABCDE::lacZYA) (Fig. 4). Statistical analysis
revealed that the numbers of serotype Enteritidis TN7 recov-
ered from mice immunized with serotype Typhimurium strain
TN4 (aroA Dlpf) were significantly lower than those recovered
from naive mice at days 17 and 28 postchallenge (P , 0.05).
The numbers of serotype Enteritidis TN7 recovered from mice
immunized with serotype Typhimurium strain TN3 (aroA lp-
fABCDE::lacZYA) were significantly lower than those recov-
ered from mice immunized with serotype Typhimurium strain
TN4 (aroA Dlpf) on days 2, 7, and 17 postchallenge (P , 0.05).
To assess whether reduced fecal shedding was indicative of
colonization of murine organs, the experiment was repeated
with groups of five mice. Prior to challenge, two animals were
removed from the group of mice immunized with strain TN3
because the animals had developed long-term carriage of the
vaccine strain. At 8 days post challenge with serotype Enteri-
tidis strain TN7 (Plac::lpfABCDE), mice were euthanized, and
bacteria in organs were enumerated (Fig. 5). Overall, the re-
sults were similar to those obtained during recovery of serotype
Enteritidis strain TN7 from fecal pellets. Mice immunized with
serotype Typhimurium strain TN3 (aroA lpfABCDE::lacZYA)
contained significantly fewer CFU of TN7 in Peyer’s patches
(P , 0.001) and mesenteric lymph nodes (P , 0.005) than
FIG. 4. Recovery of serotype Enteritidis strain TN7 (Plac::lpfABCDE)
from feces during a challenge of naive CBA/J mice and mice immunized
with serotype Typhimurium strain TN3 (aroA lpfABCDE::lacZYA) or
TN4 (aroA Dlpf). The standard errors and the average numbers of
strain TN7 recovered from feces of naive animals (solid squares) and
mice previously vaccinated with strain TN3 (open circles) or TN4
(open squares) are shown.
FIG. 5. Recovery of serotype Enteritidis strain TN7 (Plac::lpfABCDE)
at day 8 post challenge from organs of mice that were either naive (solid
squares) or previously immunized with serotype Typhimurium strain TN3
(open circles) or TN4 (open squares). Each circle or square represents
data for an individual animal. Average numbers of bacteria recovered
from an organ are indicated by a bar.
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naive mice. Furthermore, bacterial numbers recovered from
Peyer’s patches of mice immunized with serotype Typhimu-
rium strain TN3 (aroA lpfABCDE::lacZYA) were significantly
lower than those recovered from mice immunized with sero-
type Typhimurium strain TN4 (aroA Dlpf) (P , 0.25). Al-
though numbers of serotype Enteritidis strain TN7 recovered
from organs of mice immunized with serotype Typhimurium
strain TN4 (aroA Dlpf) were on average lower than those
recovered from naive mice, this difference was not statistically
significant (P . 0.1). In summary, these data showed that a
serotype Enteritidis strain expressing LP fimbriae from the lac
promoter (TN7) colonized mice previously exposed to sero-
type Typhimurium expressing LP fimbriae in significantly low-
er numbers than mice not previously exposed to serotype Ty-
phimurium LP fimbriae.
Serological response of mice immunized with serotype Ty-
phimurium. The results of the challenge experiments suggest-
ed that mice previously exposed to serotype Typhimurium strain
TN3 (aroA lpfABCDE::lacZYA) developed an immune re-
sponse against LP fimbrial proteins which resulted in reduced
fecal and organ colonization of serotype Enteritidis strain TN7
(Plac::lpfABCDE) (Fig. 4 and 5). To confirm this assumption
experimentally, antibody titers against purified GST-LpfA fu-
sion protein of serotype Enteritidis generated during vaccina-
tion with serotype Typhimurium strains TN3 (aroA lpfABCDE::
lacZYA) or TN4 (aroA Dlpf) were determined by ELISA (Table
2). The serum of mice immunized with an lpf phase ON culture
of serotype Typhimurium strain TN3 (aroA lpfABCDE::lac-
ZYA) contained 48-fold higher titers against serotype Enteri-
tidis GST-LpfA fusion protein than the serum of mice immu-
nized with serotype Typhimurium strain TN4 (aroA Dlpf). The
serum of naive mice did not react with the fusion protein (data
not shown). These data supported the idea that LpfA was
expressed during vaccination with serotype Typhimurium
strain TN3 and elicited an immune response that resulted in
cross-reactivity with serotype Enteritidis LpfA.
Although cross protection between serotypes Typhimurium
and Enteritidis is not observed during oral infection of BALB/c
mice (20), a modest reduction in numbers of serotype Enter-
itidis strain TN7 was noted when data for naive mice and mice
previously immunized with serotype Typhimurium strain TN4
(aroA Dlpf) were compared (Fig. 4 and 5). The O antigens of
serotypes Enteritidis and Typhimurium differ with respect to
their immunodominant epitopes (O9 and O4, respectively) but
possess an identical trisaccharide backbone (the O12 antigen).
The degree of cross-reactivity between LPS of serotypes Ty-
phimurium and Enteritidis with serum from immunized mice
was assessed by ELISA (Table 3). Titers against homologous
(serotype Typhimurium) LPS were consistently higher than
titers against heterologous (serotype Enteritidis) LPS. These
data thus confirmed that LPS of serotypes Typhimurium and
Enteritidis differ in their immunodominant epitopes. However,
substantial cross-reactivity between LPS of serotypes Typhi-
murium and Enteritidis was detected with serum raised against
serotype Typhimurium, presumably because of the shared an-
tigens (O12, core oligosaccharide, or lipid A).
DISCUSSION
Based on their immunodominant O antigens, Salmonella
serotypes are traditionally classified into serogroups (13). S. en-
terica serotype Typhimurium is a member of serogroup B,
which is characterized by LPS containing the O4 antigen. S. en-
terica serotype Enteritidis, on the other hand, expresses the O9
antigen, the group-specific antigen of serogroup D1. Immuni-
zation with a Salmonella serotype elicits high antibody titers
against its group-specific O antigen (e.g., O4 or O9), while
reactivity to LPS of other serogroups is usually low (26). For
instance, the serum of chickens vaccinated with S. enterica
serotype Gallinarum (serogroup D1) contains antibody titers
against LPS of serogroup D1 that are 2,048-fold, 512-fold, and
16-fold higher than those against LPS of serogroups C1 (sero-
type Virchow), C2 (serotype Hadar), and B (serotype Typhi-
murium), respectively (2). The relatively high level of cross-
reactivity between LPS of serogroups D1 and B detected with
chicken sera is due to the shared O12 antigen (6). However,
antibody titers against the O4 or O9 antigen are commonly
higher than those directed against the shared O12 antigen
(12, 18, 26). Similarly, we found that immunization of mice
with serotype Typhimurium elicited between 1.3- and 12-fold-
higher titers against its own LPS (O-antigen formula O4, 12)
than against LPS of serotype Enteritidis (O-antigen formula
O9, 12) (Table 3).
Although the differences in antibody titers against LPS of
serogroups B and D1 are modest, the group-specific O4 and
O9 antigens are important targets for protective immunity
(12). In contrast, expression of the O12 antigen by serotypes
Enteritidis and Typhimurium does not result in cross-immunity
in genetically susceptible (BALB/c) mice) (11, 12, 20). Using
genetically resistant mice (CBA/J), we found that on 2 of 18
occasions on which bacterial numbers in fecal pellets were
enumerated (days 17 and 28 postchallenge), serotype Enterit-
idis strain TN7 was recovered in significantly lower numbers
from animals vaccinated with serotype Typhimurium (TN4)
than from naive animals (Fig. 3). This low degree of cross-
immunity between serotypes Typhimurium and Enteritidis ob-
served in CBA/J mice at late time points may be due to ex-
pression of cross-reactive antigens, such as the O12 antigen.
However, since BALB/c mice succumb to infection with sero-
type Enteritidis within 6 to 10 days, cross-immunity in CBA/J
mice indicated by reduced numbers recovered from feces at
days 17 and 28 postinfection may not be indicative of protec-
tion that can be observed in BALB/c mice. Our results there-
fore do not contradict previous reports which show that
BALB/c mice vaccinated with serotype Typhimurium (sero-
group B) are not protected against challenge with serotype
Enteritidis (serogroup D1) (11, 12, 20).
TABLE 3. Serological response of mice immunized with serotype
Typhimurium against purified LPS in ELISA
LPS
Titer in serum of mice
Serotype Typhimurium vaccinated Naive
TN3 (aroA
lpfABCDE::
lacZYA)
TN4
(aroA Dlpf) IgG IgA
IgG IgA IgG IgA
Typhimurium 1,600 120 3,200 160 ,10 ,10
Enteritidis 600 ,10 2,400 60 ,10 ,10
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To assess the role of LP fimbrial phase variation in evading
cross-immunity between serotypes Typhimurium and Enterit-
idis, we constructed a serotype Enteritidis strain (TN7) in
which the yhjY-lpfA intergenic region was replaced by the lac
promoter (Fig. 2). Expression of LpfA by TN7 (Plac::lpfABCDE)
was confirmed by ELISA (Table 2). Constitutive expression of
type 1 fimbriae reduces the ability of E. coli to colonize mice.
For instance, during competitive infection experiments, an E.
coli mutant in which expression of type 1 fimbriae is locked ON
colonizes the mouse large intestine at lower levels than the
isogenic wild type in which expression of the fim operon is
regulated by phase variation (17). In contrast, serotype Enter-
itidis strain TN7 (Plac::lpfABCDE) was recovered at similar
numbers as the isogenic wild type (TN2) from murine feces
and organs during competitive infection experiments (Fig. 3).
These data suggested that expression of the lpf operon from
the lac promoter did not markedly reduce the ability of sero-
type Enteritidis to colonize the intestine or internal organs of
mice.
We have previously shown that immunization of mice with
an lpf phase ON culture of serotype Typhimurium results in
selection against lpf phase ON variants of serotype Enteritidis
during a subsequent challenge. However, the total numbers of
serotype Enteritidis recovered during the challenge from fecal
pellets or organs of mice immunized with an lpf phase ON
culture of serotype Typhimurium are not significantly different
from those recovered from a naive control group, presumably
because phase OFF variants are able to evade cross-immunity
(20). These data provide indirect evidence that fimbrial phase
variation is a mechanism to evade cross-immunity between
serotypes Typhimurium and Enteritidis. Furthermore, this hy-
pothesis predicts that cross-immunity between serotypes Ty-
phimurium and Enteritidis would be observed if a promoter
that does not undergo phase variation drove expression of LP
fimbriae. To test this prediction, mice were immunized with an
lpf phase ON culture of serotype Typhimurium (TN3) and
then challenged with serotype Enteritidis strain TN7 (Plac::
lpfABCDE). On 14 of the 18 occasions on which bacterial num-
bers in fecal pellets were enumerated postinfection, the total
numbers of serotype Enteritidis strain TN7 recovered from
mice immunized with serotype Typhimurium strain TN3 were
significantly lower than those recovered from a naive control
group. Statistically significant differences were detected as
early as 2 days postchallenge, and the difference was largest on
day 19 postchallenge, when the average number of serotype
Enteritidis TN7 recovered from naive mice was approximately
5,500-fold higher that that recovered from mice immunized
with serotype Typhimurium strain TN3 (aroA lpfABCDE::
lacZYA) (Fig. 4). Furthermore, significantly smaller numbers of
serotype Enteritidis strain TN7 (Plac::lpfABCDE) were recov-
ered at 8 days postinfection from Peyer’s patches (P , 0.001)
and mesenteric lymph nodes (P , 0.005) of mice immunized
with an lpf phase ON culture of serotype Typhimurium (TN3)
than from the organs of naive mice (Fig. 5). In contrast, the
numbers of serotype Enteritidis strain TN7 recovered from
organs of mice immunized with a Typhimurium lpf deletion
mutant (TN4) were not significantly different from those re-
covered from naive mice (P . 0.1). Serum of mice immunized
with an lpf phase ON culture of serotype Typhimurium (TN3)
reacted with GST-LpfA fusion protein of serotype Enteritidis,
suggesting in vivo expression of LpfA by the vaccine strain
(TN3) (Table 2). These data further suggested that exposure to
LP fimbrial proteins of serotype Typhimurium elicited the pro-
duction of antibodies with cross-reactivity against LP fimbrial
proteins of serotype Enteritidis.
In summary, we showed that exposure to LP fimbrial pro-
teins during infection with serotype Typhimurium resulted in
selection against a serotype Enteritidis strain expressing the lpf
operon from the lac promoter, giving rise to significantly re-
duced bacterial numbers in feces and organs. These data di-
rectly support the hypothesis that LP fimbrial phase variation
is a mechanism to evade cross-immunity between S. enterica
serotypes Typhimurium and Enteritidis.
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